⏳ Fetching live dividend data...
Home › Calculator › BIESF Dividend Calculator 2026
Biotest AG · OTC
Price: $32.00 · Annual div: $0.0455/share · Frequency: annual · Payout ratio: N/A · Ex-div: 2026-07-23
BIESF is not a dividend-focused stock
BIESF pays a very low or no dividend (Yield: 0.14%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
BIESF (Biotest AG) has a dividend yield of 0.14%, based on an annual dividend of $0.0455 per share and a price of $32.00. Over the last 12 months it paid $0.0455 per share — a trailing yield of 0.14%. Dividends are paid annual.
Yield history: over the last 3 payments, BIESF's 12-month yield ranged from 0.15% to 0.23%. Full BIESF dividend history ↓
With dividends reinvested, a BIESF position grows its share count by about 0.13% in the first year at today's price and yield.
| Year | Shares bought by dividends | Total shares |
|---|
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-07-23Latest | 2026-07-24 | $0.0455 | — | — |
| 2025-07-03 | 2025-07-07 | $0.0470 | — | — |
| 2024-05-08 | 2024-05-13 | $0.0468 | 0.15% | $30.48 |
| 2022-05-06 | 2022-05-10 | $0.0468 | 0.23% | $41.45 |
| 2021-05-12 | 2021-05-17 | $0.0468 | 0.21% | $22.31 |
| 2020-05-11 | 2020-05-13 | $0.0468 | — | — |
| 2019-05-08 | 2019-05-10 | $0.0468 | — | — |
| 2018-05-16 | 2018-05-18 | $0.0468 | — | — |
| 2017-08-31 | 2017-09-04 | $0.0819 | — | — |
| 2016-05-13 | 2016-05-13 | $0.0468 | — | — |
| 2015-05-08 | 2015-05-08 | $0.2574 | — | — |
| 2014-05-08 | 2014-05-08 | $0.2457 | — | — |
| 2013-05-09 | 2013-05-10 | $0.7339 | — | — |
| 2012-05-11 | 2012-05-11 | $0.6469 | — | — |
| 2011-05-13 | 2011-05-13 | $0.6222 | — | — |
| 2010-05-07 | 2010-05-07 | $0.5087 | — | — |
| 2009-05-08 | 2009-05-08 | $0.4854 | — | — |
| 2008-05-28 | 2008-05-28 | $0.5636 | — | — |
| 2007-05-04 | 2007-05-04 | $0.4076 | — | — |
| 2006-05-12 | 2006-05-12 | $0.2321 | — | — |
| 2005-05-23 | 2005-05-23 | $0.1382 | — | — |
| 2004-07-09 | 2004-07-09 | $0.2726 | — | — |
| 2002-07-12 | 2002-07-12 | $0.3067 | — | — |
| 2001-07-13 | 2001-07-13 | $0.2647 | — | — |
| 2000-07-17 | 2000-07-17 | $0.2440 | — | — |
| 1999-07-16 | 1999-07-16 | $0.2609 | — | — |
| 1998-07-10 | 1998-07-10 | $0.5485 | — | — |
| 1997-07-21 | 1997-07-21 | $0.5574 | — | — |
| 1996-07-22 | 1996-07-22 | $0.5368 | — | — |
| 1995-07-24 | 1995-07-24 | $0.5778 | — | — |
| 1994-07-25 | 1994-07-25 | $0.4406 | — | — |
| 1993-07-26 | 1993-07-26 | $0.3478 | — | — |
| 1992-07-27 | 1992-07-27 | $0.5383 | — | — |
| 1991-07-15 | 1991-07-15 | $0.4466 | — | — |
| 1990-06-25 | 1990-06-25 | $0.4770 | — | — |
| 1989-07-24 | 1989-07-24 | $0.4198 | — | — |
| 1988-07-25 | 1988-07-25 | $0.1089 | — | — |
Biotest Aktiengesellschaft, a German biopharmaceutical company established in Dreieich in 1946, specializes in the research, development, production, and global commercialization of advanced biological therapeutics. Its operations are organized into key segments: Therapy, Plasma & Services, and Other. The company’s primary focus areas encompass critical medical needs within hematology (blood disorders), clinical immunology, and intensive care medicine. Biotest offers a comprehensive range of products, including specific treatments for hemophilia like Haemoctin and Vihuma for the acute and prophylactic management of hemophilia A, and Haemonine for similar applications in hemophilia B. Its portfolio also features immunotherapies such as Cytotect CP biotest for cytomegalovirus infections, Fovepta for hepatitis B prophylaxis in neonates, and Hepatect for preventing hepatitis B reinfection. Varitect addresses varicella zoster virus infections, while Intratect and IgG Next Generation are utilized for primary immune and secondary antibody deficiency syndromes, autoimmune conditions, and certain neurological indications. Additionally, Zutectra is available for hepatitis B re-infection prophylaxis following liver transplantation. Further extending its product line, Biotest provides solutions like Albiomin and Biseko to restore and sustain circulating blood volume, Cofact for clotting factor deficiencies, and Fibrinogen for congenital fibrinogen deficiency. Innovative treatments include Trimodulin for community-acquired pneumonia and COVID-19, as well as Pentaglobin for bacterial infections. Known as Biotest Serum-Institut GmbH until its renaming in 1986, the company has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
BIESF (Biotest AG) has a dividend yield of 0.14%, based on an annual dividend of $0.0455 per share and a price of $32.00. Over the last 12 months it paid $0.0455 per share — a trailing yield of 0.14%. Dividends are paid annual.
$10,000 in BIESF at a 0.14% yield pays about $14 a year ($1 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a BIESF position grows its share count by about 0.13% in the first year at today's price and yield.
Enter your starting amount, monthly contribution and time horizon in the BIESF DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
BIESF's next ex-dividend date has not been announced yet; the most recent one was 2026-07-23. BIESF pays dividends annual. Buy before the ex-dividend date to receive the next payment.
BIESF's dividend changed -3.2% over the last year and 0.0% a year on average over five years.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BIESF position with:
Real after-tax yield depends on where you live and how you hold BIESF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.14% | -2.66% | $14 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.12% | -2.68% | $12 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.11% | -2.69% | $11 / yr |
| 🇬🇧 UK ISA | 0% | 0.14% | -2.66% | $14 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.13% | -2.67% | $13 / yr |
| 🇨🇦 TFSA | 0% | 0.14% | -2.66% | $14 / yr |
| 🇨🇦 CA Taxable | 25% | 0.11% | -2.69% | $11 / yr |
| 🇦🇺 Super (pension) | 15% | 0.12% | -2.68% | $12 / yr |
| 🇦🇺 AU Taxable | 30% | 0.10% | -2.70% | $10 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.10% | -2.70% | $10 / yr |
| 🇫🇷 FR Taxable | 30% | 0.10% | -2.70% | $10 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.05/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BIESF pays annually — 1 payment per year.
How BIESF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BIESF sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare BIESF with peers: BIESF vs BITGF · BIESF vs CKDXF · BIESF vs CMPUY
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BIESF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Biotest AG (BIESF) is currently trading at $32.00, trading near its 52-week high. The current dividend yield is 0.14% based on an annual payout of $0.0455 per share.
Biotest AG (BIESF) is a healthcare stock currently trading at $32.00 with a dividend yield of 0.14%. It pays an annual dividend of $0.0455 per share.
Auto-generated from live market data. For educational purposes only — not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.
| Dividend income |
|---|
| Position value |
|---|
| Yield on cost |
|---|
| 1 | 0.42 | 312.92 | $14 | $10,614 | 0.14% |
| 3 | 0.37 | 313.69 | $14 | $11,955 | 0.14% |
| 5 | 0.33 | 314.38 | $14 | $13,463 | 0.14% |
| 10 | 0.25 | 315.79 | $14 | $18,097 | 0.14% |
| 20 | 0.14 | 317.64 | $14 | $32,598 | 0.14% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work →
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever